English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived anti-cancer drugs

MPS-Authors
/persons/resource/persons244889

Langley,  Chloe
Department of Natural Product Biosynthesis, Prof. Dr. Sarah O'Connor, MPI for Chemical Ecology, Max Planck Society;
IMPRS on Ecological Interactions, MPI for Chemical Ecology, Max Planck Society;

/persons/resource/persons244870

Grzech,  Dagny
Department of Natural Product Biosynthesis, Prof. Dr. Sarah O'Connor, MPI for Chemical Ecology, Max Planck Society;
IMPRS on Ecological Interactions, MPI for Chemical Ecology, Max Planck Society;

/persons/resource/persons228440

O’Connor,  Sarah E.
Department of Natural Product Biosynthesis, Prof. Dr. Sarah O'Connor, MPI for Chemical Ecology, Max Planck Society;

External Ressource
Fulltext (public)

SOC092.pdf
(Publisher version), 744KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Carqueijeiro, I., Langley, C., Grzech, D., Koudounas, K., Papon, N., O’Connor, S. E., et al. (2020). Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived anti-cancer drugs. Current Opinion in Biotechnology, 65, 17-24. doi:10.1016/j.copbio.2019.11.017.


Cite as: http://hdl.handle.net/21.11116/0000-0005-9989-4
Abstract
There is no abstract available